The Hash Corporation

PINK:REZNF USA Drug Manufacturers - Specialty & Generic
Market Cap
$588.94K
Market Cap Rank
#41411 Global
#13470 in USA
Share Price
$0.00
Change (1 day)
+250.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.02
About

Street Capital Inc. focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada. It applies its separation and curing techniques to produce a suite of cannabis resin products, which are natural and free of additives. The company was formerly known as The Hash Corporation and changed its name to Street Capital Inc. in November 2024. Street Capital Inc. was in… Read more

The Hash Corporation (REZNF) - Net Assets

Latest net assets as of September 2024: $-550.15K USD

Based on the latest financial reports, The Hash Corporation (REZNF) has net assets worth $-550.15K USD as of September 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($283.48K) and total liabilities ($833.62K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-550.15K
% of Total Assets -194.07%
Annual Growth Rate N/A
5-Year Change -116.22%
10-Year Change N/A
Growth Volatility 15888.61

The Hash Corporation - Net Assets Trend (2013–2023)

This chart illustrates how The Hash Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for The Hash Corporation (2013–2023)

The table below shows the annual net assets of The Hash Corporation from 2013 to 2023.

Year Net Assets Change
2023-12-31 $-396.22K -3084.82%
2022-12-31 $-12.44K -101.07%
2021-12-31 $1.16 Million -42.81%
2020-12-31 $2.04 Million -16.67%
2019-12-31 $2.44 Million +36639.60%
2018-12-31 $6.65K +104.17%
2017-12-31 $-159.57K +54.57%
2016-12-31 $-351.27K -12.15%
2015-12-31 $-313.21K -35.72%
2014-12-31 $-230.77K +47.56%
2013-12-31 $-440.05K --

Equity Component Analysis

This analysis shows how different components contribute to The Hash Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1097430500.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Common Stock $11.97 Million %
Other Components $2.08 Million %
Total Equity $-396.22K 100.00%

The Hash Corporation Competitors by Market Cap

The table below lists competitors of The Hash Corporation ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in The Hash Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from -12,441 to -396,223, a change of -383,782.
  • Net loss of 420,000 reduced equity.
  • Other comprehensive income decreased equity by 98,948.
  • Other factors increased equity by 135,166.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $-420.00K -106.0%
Other Comprehensive Income $-98.95K -24.97%
Other Changes $135.17K +34.11%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares The Hash Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 $-0.26 $0.00 x
2014-12-31 $-0.08 $0.00 x
2015-12-31 $-0.11 $0.00 x
2016-12-31 $-0.13 $0.00 x
2017-12-31 $-0.06 $0.00 x
2018-12-31 $0.00 $0.00 x
2019-12-31 $0.01 $0.00 x
2020-12-31 $0.01 $0.00 x
2021-12-31 $0.00 $0.00 x
2022-12-31 $0.00 $0.00 x
2023-12-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently The Hash Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -75.82%
  • • Asset Turnover: 2.12x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-423.36%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 0.00% 0.00% 0.00x 0.00x $-180.99K
2014 0.00% 0.00% 0.00x 0.00x $-222.92K
2015 0.00% 0.00% 0.00x 0.00x $-51.12K
2016 0.00% 0.00% 0.00x 0.00x $-2.93K
2017 0.00% 0.00% 0.00x 0.00x $207.65K
2018 -4075.80% 0.00% 0.00x 15.90x $-271.66K
2019 -83.56% 0.00% 0.00x 1.10x $-2.29 Million
2020 -99.28% -2207.30% 0.04x 1.11x $-2.22 Million
2021 -398.30% -560.63% 0.59x 1.21x $-4.75 Million
2022 0.00% -174.90% 1.60x 0.00x $-1.41 Million
2023 0.00% -75.82% 2.12x 0.00x $-380.38K

Industry Comparison

This section compares The Hash Corporation's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
The Hash Corporation (REZNF) $-550.15K 0.00% N/A $84.13K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million